CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

You May Also Be Interested In

• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• Grocery Outlet Holding (GO) PT Raised to $12 at TD Cowen